Zdrowie i gospodarka · 11/06/2026
FDA Extends Comment Period for Drug Repurposing Notice
The US Food and Drug Administration is extending the comment period for a notice on drug repurposing for unmet medical needs, allowing more time for public input on the agency's efforts in this area.